GlassScriptPhysician profile
Susan H Longe
NPI 1194827857
$942.49
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $77.99 · 2021: $325 · 2022: $94.42 · 2023: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $300.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $193.30 | 2020-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $165.94 | 2019-2023 | Rybelsus, Ozempic |
| Lilly USA, LLC | $117.95 | 2019-2023 | Mounjaro |
| Abbvie INC. | $84.09 | 2021-2023 | |
| Eisai INC. | $46.16 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $45.31 | 2021-2023 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $41.21 | 2019-2021 | |
| Astellas Pharma US INC | $33.33 | 2023 | Veozah |
| Janssen Pharmaceuticals, INC | $30.20 | 2019-2020 | |
| Mylan Specialty L.P. | $29.23 | 2021 | |
| Abbott Laboratories | $20.05 | 2022 | |
| Exact Sciences Corporation | $18.82 | 2023 | Cologuard Collection Kit |
| Idorsia Pharmaceuticals US INC | $18.03 | 2023 | Quviviq |
| Dexcom, INC. | $17.10 | 2022 | |
| Kaleo, INC. | $15.66 | 2023 | Auvi-Q |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $14.04 | 2021 | |
| Radius Health, INC. | $13.80 | 2019 | |
| Sanofi-Aventis U.S. LLC | $13.72 | 2019 | |
| Smith+Nephew, INC. | $12.89 | 2023 | Oasis Micro |
| Pfizer INC. | $11.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Longe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.